Andrew Kittle CBD, Inc. – Trademark Portfolio
Entity Type: 03
Andrew Kittle CBD, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PIMP MY HEMP. The owner is based in San Antonio, TX.
502 Pershing Ave.
San Antonio, TX 78209
Showing of trademarks Trademarks
Trademark Classifications
Andrew Kittle CBD, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Andrew Kittle CBD, Inc. have?
Andrew Kittle CBD, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 1 cancelled.
What trademark classes does Andrew Kittle CBD, Inc. file in?
Andrew Kittle CBD, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Andrew Kittle CBD, Inc.'s most well-known trademarks?
Andrew Kittle CBD, Inc.'s registered trademark portfolio includes well-known marks such as PIMP MY HEMP. These are among 1 currently registered trademark in the portfolio.
What is Andrew Kittle CBD, Inc.'s trademark registration success rate?
Andrew Kittle CBD, Inc. has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.